State VA
Clinical Trials in Virginia
Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Virginia
Frequently Asked Questions — Clinical Trials in Virginia
How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 287 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 287. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Virginia
NCT06745908 Phase 3
Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhi...
Condition
NSCLC Stage IV
Enrollment
507 pts
Location
United States
Sponsor
ImmunityBio, Inc.
NCT06948214 Phase 3
Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Condition
Growth Hormone Deficiency (GHD)
Enrollment
150 pts
Location
United States, Australia, New Zealand
Sponsor
Lumos Pharma
NCT06964464 Phase 4
Recruiting
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Fai...
Condition
Heart Failure With Reduced Ejection Fraction (HFrEF)
Enrollment
2,000 pts
Location
United States
Sponsor
University of Rochester
NCT07149363 Phase 2
Recruiting
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung ...
Condition
Small Cell Lung Cancer (SCLC)
Enrollment
65 pts
Location
United States
Sponsor
Alliance Foundation Trials, LL
NCT06248606 Phase 2
Recruiting
Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untrea...
Condition
Non Small Cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Ryan Gentzler, MD
NCT07321106 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumo...
Condition
Colorectal Cancer
Enrollment
80 pts
Location
United States
Sponsor
Cartography Biosciences
NCT07137598 Phase 2
Recruiting
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Mode...
Condition
Rheumatoid Arthritis
Enrollment
160 pts
Location
United States, Argentina, Belgium
Sponsor
Hoffmann-La Roche
NCT04888832 N/A
Recruiting
The Effect of Work Requirements in SNAP in Virginia
Condition
Health Disparities
Enrollment
12,500 pts
Location
United States
Sponsor
Harvard Medical School (HMS an
NCT06958211 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants W...
Condition
Hidradenitis Suppurativa
Enrollment
550 pts
Location
United States, Belgium, Bulgaria
Sponsor
Incyte Corporation
NCT04042844 Phase 2
Recruiting
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition
Lumbar Disc Disease
Enrollment
99 pts
Location
United States
Sponsor
BioRestorative Therapies
NCT06616363 N/A
Recruiting
Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx ...
Condition
POTS - Postural Orthostatic Tachycardia Syndrome
Enrollment
120 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT05980949 Phase 3
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Ka...
Condition
Psychosis Associated With Alzheimer's Disease
Enrollment
800 pts
Location
United States, Argentina, Belgium
Sponsor
Karuna Therapeutics, Inc., a B
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06710132 Phase 1, Phase 2
Recruiting
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROC...
Condition
Solid Tumors
Enrollment
250 pts
Location
United States, Australia, Austria
Sponsor
EMD Serono Research & Developm
NCT04637763 Phase 1
Recruiting
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B ...
Condition
Lymphoma, Non-Hodgkin
Enrollment
72 pts
Location
United States, Australia, Israel
Sponsor
Caribou Biosciences, Inc.
NCT06911502 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Ri...
Condition
Follicular Lymphoma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Celgene
NCT03476681 Phase 1, Phase 2
Recruiting
Study of NEO-201 in Solid Tumors Expansion Cohorts
Condition
Non Small Cell Lung Cancer
Enrollment
121 pts
Location
United States
Sponsor
Precision Biologics, Inc
NCT06428409 Phase 1, Phase 2
Recruiting
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointest...
Condition
Colorectal Cancer
Enrollment
220 pts
Location
United States, Australia, Canada
Sponsor
Merck Sharp & Dohme LLC
NCT05867251 Phase 1, Phase 2
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
430 pts
Location
United States, Australia
Sponsor
Avenzo Therapeutics, Inc.
NCT05426967 N/A
Recruiting
rTMS for Military TBI-related Depression
Condition
Depressive Symptoms
Enrollment
198 pts
Location
United States
Sponsor
Henry M. Jackson Foundation fo
NCT07449936 Phase 3
Recruiting
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-19...
Condition
Diabetic Macular Edema
Enrollment
240 pts
Location
United States
Sponsor
EyePoint Pharmaceuticals, Inc.
NCT06909565 Phase 4
Recruiting
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and...
Condition
Percutaneous Coronary Intervention
Enrollment
6,000 pts
Location
United States
Sponsor
Duke University
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06023186 N/A
Recruiting
Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
20 pts
Location
United States
Sponsor
Michael Ayers
NCT06060860 N/A
Recruiting
Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Auti...
Condition
Autism Spectrum Disorder
Enrollment
300 pts
Location
United States
Sponsor
University of North Carolina,
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology